Skip to main content
Top
Published in: Child's Nervous System 1/2009

01-01-2009 | Original Paper

Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine

Authors: Elvis Terci Valera, Maria Angélica Abdalla de Freitas Cortez, Rosane Gomes de Paula Queiroz, Fabio Morato de Oliveira, María Sol Brassesco, Nada Jabado, Damien Faury, Michael S. Bobola, Hélio Rubens Machado, Carlos Alberto Scrideli, Luiz Gonzaga Tone

Published in: Child's Nervous System | Issue 1/2009

Login to get access

Abstract

Background

Resistance to drug is a major cause of treatment failure in pediatric brain cancer. The multidrug resistance (MDR) phenotype can be mediated by the superfamily of adenosine triphosphate-binding cassette (ABC) transporters. The dynamics of expression of the MDR genes after exposure to chemotherapy, especially the comparison between pediatric brain tumors of different histology, is poorly described.

Objective

To compare the expression profiles of the multidrug resistance genes ABCB1, ABCC1, and ABCG2 in different neuroepithelial pediatric brain tumor cell lines prior and following short-term culture with vinblastine.

Methods

Immortalized lineages from pilocytic astrocytoma (R286), anaplasic astrocytoma (UW467), glioblastoma (SF188), and medulloblastoma (UW3) were exposed to vinblastine sulphate at different schedules (10 and 60 nM for 24 and 72 h). Relative amounts of mRNA expression were analyzed by real-time quantitative polymerase chain reaction. Protein expression was assessed by immunohistochemistry for ABCB1, ABCC1, and ABCG2.

Results

mRNA expression of ABCB1 increased together with augmenting concentration and time of exposure to vinblastine for R286, UW467, and UW3 cell lines. Interestingly, ABCB1 levels of expression diminished in SF188. Following chemotherapy, mRNA expression of ABCC1 decreased in all cell lines other than glioblastoma. ABCG2 expression was influenced by vinblastine only for UW3. The mRNA levels showed consistent association to protein expression in the selected sets of cell lines analyzed.

Conclusions

The pediatric glioblastoma cell line SF188 shows different pattern of expression of multidrug resistance genes when exposed to vinblastine. These preliminary findings may be useful in determining novel strategies of treatment for neuroepithelial pediatric brain tumors.
Literature
1.
go back to reference Bredel M, Zentner J (2002) Brain-tumour drug resistance: the bare essentials. Lancet Oncol 3(7):397–406PubMedCrossRef Bredel M, Zentner J (2002) Brain-tumour drug resistance: the bare essentials. Lancet Oncol 3(7):397–406PubMedCrossRef
2.
go back to reference Bredel M (2001) Anticancer drug resistance in primary human brain tumors. Brain Res Rev 35:161–204PubMedCrossRef Bredel M (2001) Anticancer drug resistance in primary human brain tumors. Brain Res Rev 35:161–204PubMedCrossRef
3.
go back to reference Bronger H, Konig J, Kopplow K, Steiner HH, Ahmadi R, Herold-Mende C, Keppler D, Nies AT (2005) ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res 65(24):11419–11428PubMedCrossRef Bronger H, Konig J, Kopplow K, Steiner HH, Ahmadi R, Herold-Mende C, Keppler D, Nies AT (2005) ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res 65(24):11419–11428PubMedCrossRef
4.
go back to reference Chou PM, Reyes-Mugica M, Barquin N, Yasuda T, Tan X, Tomita T (1995) Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients. Pediatr Neurosurg 23(6):283–291PubMedCrossRef Chou PM, Reyes-Mugica M, Barquin N, Yasuda T, Tan X, Tomita T (1995) Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients. Pediatr Neurosurg 23(6):283–291PubMedCrossRef
5.
go back to reference de Bruijn MH, Van der Bliek AM, Biedler JL, Borst P (1986) Differential amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines. Mol Cell Biol 6(12):4717–4722PubMed de Bruijn MH, Van der Bliek AM, Biedler JL, Borst P (1986) Differential amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines. Mol Cell Biol 6(12):4717–4722PubMed
6.
go back to reference Decleves X, Fajac A, Lehmann-Che J, Tardy M, Mercier C, Hurbain I, Laplanche JL, Bernaudin JF, Scherrmann JM (2006) Molecular and functional MDR1-Pgp and MRPs expression in human glioblastomas multiforme cell lines. Int J Cancer 98(2):173–180CrossRef Decleves X, Fajac A, Lehmann-Che J, Tardy M, Mercier C, Hurbain I, Laplanche JL, Bernaudin JF, Scherrmann JM (2006) Molecular and functional MDR1-Pgp and MRPs expression in human glioblastomas multiforme cell lines. Int J Cancer 98(2):173–180CrossRef
7.
go back to reference Ee PL, Kamalakaran S, Tonetti D, He X, Ross DD, Beck WT (2004) Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res 64:1247–1251PubMedCrossRef Ee PL, Kamalakaran S, Tonetti D, He X, Ross DD, Beck WT (2004) Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res 64:1247–1251PubMedCrossRef
8.
go back to reference Fruehauf JP (2006) In vitro drug response and molecular markers associated with drug resistance in malignant gliomas. Clin Cancer Res 12(15):4523–4532PubMedCrossRef Fruehauf JP (2006) In vitro drug response and molecular markers associated with drug resistance in malignant gliomas. Clin Cancer Res 12(15):4523–4532PubMedCrossRef
9.
go back to reference Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385–427PubMedCrossRef Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385–427PubMedCrossRef
10.
go back to reference Higgins CF, Linton KJ (2004) The ATP switch model for ABC transporters. Nat Struct Mol Biol 11(10):918–926PubMedCrossRef Higgins CF, Linton KJ (2004) The ATP switch model for ABC transporters. Nat Struct Mol Biol 11(10):918–926PubMedCrossRef
11.
go back to reference Imai Y, Ishikawa E, Asada S, Sugimoto Y (2005) Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res 65:596–604PubMedCrossRef Imai Y, Ishikawa E, Asada S, Sugimoto Y (2005) Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res 65:596–604PubMedCrossRef
12.
go back to reference Kurz EU, Cole SP, Deeley RG (2001) Identification of DNA-protein interactions in the 5′ flanking and 5′ untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site. Biochem Biophys Res Commun 285(4):981–990PubMedCrossRef Kurz EU, Cole SP, Deeley RG (2001) Identification of DNA-protein interactions in the 5′ flanking and 5′ untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site. Biochem Biophys Res Commun 285(4):981–990PubMedCrossRef
13.
go back to reference Labialle S, Gayet L, Marthinet E, Rigal D, Baggetto LG (2002) Transcriptional regulators of the human multidrug resistance 1 gene: recent views. Biochem Pharmacol 64(5–6):943–948PubMedCrossRef Labialle S, Gayet L, Marthinet E, Rigal D, Baggetto LG (2002) Transcriptional regulators of the human multidrug resistance 1 gene: recent views. Biochem Pharmacol 64(5–6):943–948PubMedCrossRef
14.
go back to reference Livak K, Schmittgen T (2001) Analysis of gene expression data using real-time quantitative PCR and \(2^{{ - \Delta \Delta CT}}\) method. Methods 25:402–408PubMedCrossRef Livak K, Schmittgen T (2001) Analysis of gene expression data using real-time quantitative PCR and \(2^{{ - \Delta \Delta CT}}\) method. Methods 25:402–408PubMedCrossRef
15.
go back to reference Nagane M (2005) Chemoresistance-related genes and individualized adjuvant therapies for brain gliomas. Nippon Rinsho 63(Suppl 9):460–471PubMed Nagane M (2005) Chemoresistance-related genes and individualized adjuvant therapies for brain gliomas. Nippon Rinsho 63(Suppl 9):460–471PubMed
16.
go back to reference Polgar O, Robey RW, Bates SE (2008) ABCG2: structure, function and role in drug response. Expert Opin Drug Metab Toxicol 4(1):1–15PubMedCrossRef Polgar O, Robey RW, Bates SE (2008) ABCG2: structure, function and role in drug response. Expert Opin Drug Metab Toxicol 4(1):1–15PubMedCrossRef
17.
go back to reference Potter R, Czech TH, Diekmann K, Slavc I, Wimberger-Prayer D, Budka H (1998) Tumours of central nervous system. In: Voûte PA, Kalifa C, Barret A (eds) Cancer in children—clinical management. Oxford University Press, Oxford, pp 172–192 Potter R, Czech TH, Diekmann K, Slavc I, Wimberger-Prayer D, Budka H (1998) Tumours of central nervous system. In: Voûte PA, Kalifa C, Barret A (eds) Cancer in children—clinical management. Oxford University Press, Oxford, pp 172–192
18.
go back to reference Regina A, Demeule M, Laplante A, Jodoin J, Dagenais C, Berthelet F, Moghrabi A, Beliveau R (2001) Multidrug resistance in brain tumors: roles of the blood-brain barrier. Cancer Metastasis Rev 20(1–2):13–25PubMedCrossRef Regina A, Demeule M, Laplante A, Jodoin J, Dagenais C, Berthelet F, Moghrabi A, Beliveau R (2001) Multidrug resistance in brain tumors: roles of the blood-brain barrier. Cancer Metastasis Rev 20(1–2):13–25PubMedCrossRef
19.
go back to reference Robey RW, Shukla S, Steadman K, Obrzut T, Finley EM, Ambudkar SV, Bates SE (2007) Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure. Mol Cancer Ther 6(6):1877–1885PubMedCrossRef Robey RW, Shukla S, Steadman K, Obrzut T, Finley EM, Ambudkar SV, Bates SE (2007) Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure. Mol Cancer Ther 6(6):1877–1885PubMedCrossRef
20.
go back to reference Sadanand V, Kankesan J, Yusuf A, Stewart C, Rutka JT, Thiessen JJ, Ling V, Rao PM, Rajalakshmi S, Sarma DS (2003) Effect of PSC 833, a potent inhibitor of P-glycoprotein, on the growth of astrocytoma cells in vitro. Cancer Lett 198(1):21–27PubMedCrossRef Sadanand V, Kankesan J, Yusuf A, Stewart C, Rutka JT, Thiessen JJ, Ling V, Rao PM, Rajalakshmi S, Sarma DS (2003) Effect of PSC 833, a potent inhibitor of P-glycoprotein, on the growth of astrocytoma cells in vitro. Cancer Lett 198(1):21–27PubMedCrossRef
21.
go back to reference Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM (1986) Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science 232(4750):643–645PubMedCrossRef Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I, Gottesman MM (1986) Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science 232(4750):643–645PubMedCrossRef
22.
go back to reference Shirasaka Y, Onishi Y, Sakurai A, Nakagawa H, Ishikawa T, Yamashita S (2006) Evaluation of human P-glycoprotein (MDR1/ABCB1) ATPase activity assay method by comparing with in vitro transport measurements: Michaelis–Menten kinetic analysis to estimate the affinity of P-glycoprotein to drugs. Biol Pharm Bull 29(12):2465–2471PubMedCrossRef Shirasaka Y, Onishi Y, Sakurai A, Nakagawa H, Ishikawa T, Yamashita S (2006) Evaluation of human P-glycoprotein (MDR1/ABCB1) ATPase activity assay method by comparing with in vitro transport measurements: Michaelis–Menten kinetic analysis to estimate the affinity of P-glycoprotein to drugs. Biol Pharm Bull 29(12):2465–2471PubMedCrossRef
23.
go back to reference Szakàcs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5(3):219–234PubMedCrossRef Szakàcs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5(3):219–234PubMedCrossRef
24.
go back to reference Valera ET, Lucio-Eterovic AK, Neder L, Scrideli CA, Machado HR, Carlotti-Junior CG, Queiroz RG, Motta FJ, Tone LG (2007) Quantitative PCR analysis of the expression profile of genes related to multiple drug resistance in tumors of the central nervous system. J Neurooncol 85(1):1–10PubMedCrossRef Valera ET, Lucio-Eterovic AK, Neder L, Scrideli CA, Machado HR, Carlotti-Junior CG, Queiroz RG, Motta FJ, Tone LG (2007) Quantitative PCR analysis of the expression profile of genes related to multiple drug resistance in tumors of the central nervous system. J Neurooncol 85(1):1–10PubMedCrossRef
25.
go back to reference Wang H, Zhou L, Gupta A, Vethanayagam RR, Zhang Y, Unadkat JD et al (2006) Regulation of BCRP/ABCG2 expression by progesterone and 17{beta}-estradiol in human placental BeWo cells. Am J Physiol Endocrinol Metab 290(5):798–807CrossRef Wang H, Zhou L, Gupta A, Vethanayagam RR, Zhang Y, Unadkat JD et al (2006) Regulation of BCRP/ABCG2 expression by progesterone and 17{beta}-estradiol in human placental BeWo cells. Am J Physiol Endocrinol Metab 290(5):798–807CrossRef
26.
go back to reference Wu CP, Shukla S, Calcagno AM, Hall MD, Gottesman MM, Ambudkar SV (2007) Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporter. Mol Cancer Ther 6(12 Pt 1):3287–3296PubMedCrossRef Wu CP, Shukla S, Calcagno AM, Hall MD, Gottesman MM, Ambudkar SV (2007) Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporter. Mol Cancer Ther 6(12 Pt 1):3287–3296PubMedCrossRef
27.
go back to reference Yasuda S, Itagaki S, Hirano T, Iseki K (2005) Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation. Biosci Biotechnol Biochem 69:1871–1876PubMedCrossRef Yasuda S, Itagaki S, Hirano T, Iseki K (2005) Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation. Biosci Biotechnol Biochem 69:1871–1876PubMedCrossRef
Metadata
Title
Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine
Authors
Elvis Terci Valera
Maria Angélica Abdalla de Freitas Cortez
Rosane Gomes de Paula Queiroz
Fabio Morato de Oliveira
María Sol Brassesco
Nada Jabado
Damien Faury
Michael S. Bobola
Hélio Rubens Machado
Carlos Alberto Scrideli
Luiz Gonzaga Tone
Publication date
01-01-2009
Publisher
Springer-Verlag
Published in
Child's Nervous System / Issue 1/2009
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-008-0740-3

Other articles of this Issue 1/2009

Child's Nervous System 1/2009 Go to the issue